Most patients with hyperkalemia are asymptomatic or have nonspecific features only.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[12]Rossignol P, Legrand M, Kosiborod M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Nov;113(pt a):585-91.
https://www.doi.org/10.1016/j.phrs.2016.09.039
http://www.ncbi.nlm.nih.gov/pubmed/27693804?tool=bestpractice.com
However, be aware that some patients with significant hyperkalemia may present with cardiac arrest, which is not covered in this topic.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[12]Rossignol P, Legrand M, Kosiborod M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Nov;113(pt a):585-91.
https://www.doi.org/10.1016/j.phrs.2016.09.039
http://www.ncbi.nlm.nih.gov/pubmed/27693804?tool=bestpractice.com
See Cardiac arrest.
A thorough history is key for a patient with suspected or confirmed hyperkalemia in order to check for underlying causes and exclude pseudohyperkalemia, spurious hyperkalemia, and cellular redistribution of potassium.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
If hyperkalemia is suspected, take the following key steps:
Confirm elevation of potassium (potassium ≥5.5 mEq/L (≥5.5 mmol/L]) and severity of hyperkalemia using serum potassium or blood gas measurement[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Obtain an urgent 12-lead ECG in all hospitalized patients with a serum potassium ≥6.0 mEq/L (≥6.0 mmol/L; or use the threshold in your local protocol) to check for ECG changes that will determine the urgency and type of treatment[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Check for kidney dysfunction and any other underlying causes of hyperkalemia.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
History
The most common features of hyperkalemia are weakness and generalized fatigue. Other common features are paresthesia and muscle cramps. These may progress to flaccid muscle paralysis.[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Occasionally a patient may describe:
Nausea and vomiting[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Diarrhea[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Shortness of breath
Chest pain
Palpitations.
There may be features of the underlying precipitant of hyperkalemia such as diarrhea and vomiting, or infection, which can cause acute kidney injury.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
Elicit any key risk factors for hyperkalemia.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
Key risk factors include:
Kidney dysfunction (particularly end-stage kidney disease), including people receiving dialysis who are fasting or have missed dialysis[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[12]Rossignol P, Legrand M, Kosiborod M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Nov;113(pt a):585-91.
https://www.doi.org/10.1016/j.phrs.2016.09.039
http://www.ncbi.nlm.nih.gov/pubmed/27693804?tool=bestpractice.com
[13]Chan KE, Thadhani RI, Maddux FW. Adherence barriers to chronic dialysis in the United States. J Am Soc Nephrol. 2014 Nov;25(11):2642-8.
https://www.doi.org/10.1681/ASN.2013111160
http://www.ncbi.nlm.nih.gov/pubmed/24762400?tool=bestpractice.com
[14]Allon M, Takeshian A, Shanklin N. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia. Kidney Int. 1993 Jan;43(1):212-7.
https://www.doi.org/10.1038/ki.1993.34
http://www.ncbi.nlm.nih.gov/pubmed/8433561?tool=bestpractice.com
[15]Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. J Am Soc Nephrol. 1995 Oct;6(4):1134-42.
https://www.doi.org/10.1681/ASN.V641134
http://www.ncbi.nlm.nih.gov/pubmed/8589279?tool=bestpractice.com
Use of renin-angiotensin-aldosterone system inhibitors (RAASi), aldosterone antagonists, or trimethoprim[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[17]Bandak G, Sang Y, Gasparini A, et al. Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm creatinine measurements (SCREAM) project. J Am Heart Assoc. 2017 Jul 19;6(7):e005428.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586281
http://www.ncbi.nlm.nih.gov/pubmed/28724651?tool=bestpractice.com
[18]Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012 Dec 6;367(23):2204-13.
https://www.doi.org/10.1056/NEJMoa1208799
http://www.ncbi.nlm.nih.gov/pubmed/23121378?tool=bestpractice.com
[19]Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013 Nov 14;369(20):1892-903.
https://www.doi.org/10.1056/NEJMoa1303154
http://www.ncbi.nlm.nih.gov/pubmed/24206457?tool=bestpractice.com
[20]ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008 Apr 10;358(15):1547-59.
https://www.doi.org/10.1056/NEJMoa0801317
http://www.ncbi.nlm.nih.gov/pubmed/18378520?tool=bestpractice.com
[21]Vukadinović D, Lavall D, Vukadinović AN, et al. True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis. Am Heart J. 2017 Jun;188:99-108.
https://www.doi.org/10.1016/j.ahj.2017.03.011
http://www.ncbi.nlm.nih.gov/pubmed/28577687?tool=bestpractice.com
[22]Velázquez H, Perazella MA, Wright FS, et al. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993 Aug 15;119(4):296-301.
http://www.ncbi.nlm.nih.gov/pubmed/8328738?tool=bestpractice.com
[23]Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022 May 3;145(18):e895-1032.
https://www.doi.org/10.1161/CIR.0000000000001063
http://www.ncbi.nlm.nih.gov/pubmed/35363499?tool=bestpractice.com
[29]American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: standards of medical care in diabetes - 2022. Diabetes Care. 2022 Jan 1;45(suppl 1):S175-84.
https://www.doi.org/10.2337/dc22-S011
http://www.ncbi.nlm.nih.gov/pubmed/34964873?tool=bestpractice.com
Heart failure[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[12]Rossignol P, Legrand M, Kosiborod M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Nov;113(pt a):585-91.
https://www.doi.org/10.1016/j.phrs.2016.09.039
http://www.ncbi.nlm.nih.gov/pubmed/27693804?tool=bestpractice.com
[23]Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022 May 3;145(18):e895-1032.
https://www.doi.org/10.1161/CIR.0000000000001063
http://www.ncbi.nlm.nih.gov/pubmed/35363499?tool=bestpractice.com
Liver disease[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
Tissue breakdown (e.g., rhabdomyolysis, trauma, tumor lysis syndrome, and severe hypothermia)[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[24]Sever MS, Erek E, Vanholder R, et al. Serum potassium in the crush syndrome victims of the Marmara disaster. Clin Nephrol. 2003 May;59(5):326-33.
http://www.ncbi.nlm.nih.gov/pubmed/12779093?tool=bestpractice.com
[25]Perkins RM, Aboudara MC, Abbott KC, et al. Resuscitative hyperkalemia in noncrush trauma: a prospective, observational study. Clin J Am Soc Nephrol. 2007 Mar;2(2):313-9.
https://www.doi.org/10.2215/CJN.03070906
http://www.ncbi.nlm.nih.gov/pubmed/17699430?tool=bestpractice.com
[26]Schaller MD, Fischer AP, Perret CH. Hyperkalemia: a prognostic factor during acute severe hypothermia. JAMA. 1990 Oct 10;264(14):1842-5.
http://www.ncbi.nlm.nih.gov/pubmed/2402043?tool=bestpractice.com
Distal renal tubule defects that affect potassium excretion.[16]Palmer BF, Clegg DJ. Hyperkalemia across the continuum of kidney function. Clin J Am Soc Nephrol. 2018 Jan 6;13(1):155-7.
https://www.doi.org/10.2215/CJN.09340817
http://www.ncbi.nlm.nih.gov/pubmed/29114006?tool=bestpractice.com
Take a careful drug history. Ask about current drugs, any recent changes to drugs, and use of over-the-counter drugs or supplements (such as intake of high doses of potassium supplements).[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
Treatment with RAASi, aldosterone antagonists, or trimethoprim is strongly associated with hyperkalemia.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[17]Bandak G, Sang Y, Gasparini A, et al. Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm creatinine measurements (SCREAM) project. J Am Heart Assoc. 2017 Jul 19;6(7):e005428.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586281
http://www.ncbi.nlm.nih.gov/pubmed/28724651?tool=bestpractice.com
[18]Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012 Dec 6;367(23):2204-13.
https://www.doi.org/10.1056/NEJMoa1208799
http://www.ncbi.nlm.nih.gov/pubmed/23121378?tool=bestpractice.com
[19]Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013 Nov 14;369(20):1892-903.
https://www.doi.org/10.1056/NEJMoa1303154
http://www.ncbi.nlm.nih.gov/pubmed/24206457?tool=bestpractice.com
[20]ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008 Apr 10;358(15):1547-59.
https://www.doi.org/10.1056/NEJMoa0801317
http://www.ncbi.nlm.nih.gov/pubmed/18378520?tool=bestpractice.com
[21]Vukadinović D, Lavall D, Vukadinović AN, et al. True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis. Am Heart J. 2017 Jun;188:99-108.
https://www.doi.org/10.1016/j.ahj.2017.03.011
http://www.ncbi.nlm.nih.gov/pubmed/28577687?tool=bestpractice.com
[22]Velázquez H, Perazella MA, Wright FS, et al. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med. 1993 Aug 15;119(4):296-301.
http://www.ncbi.nlm.nih.gov/pubmed/8328738?tool=bestpractice.com
[23]Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022 May 3;145(18):e895-1032.
https://www.doi.org/10.1161/CIR.0000000000001063
http://www.ncbi.nlm.nih.gov/pubmed/35363499?tool=bestpractice.com
[29]American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: standards of medical care in diabetes - 2022. Diabetes Care. 2022 Jan 1;45(suppl 1):S175-84.
https://www.doi.org/10.2337/dc22-S011
http://www.ncbi.nlm.nih.gov/pubmed/34964873?tool=bestpractice.com
However, many other drugs can cause hyperkalemia, particularly when taken in combination with RAASi or aldosterone antagonists, and if there is concurrent kidney dysfunction. These include, but are not limited to:
Arginine[56]Cremades A, Del Rio-Garcia J, Lambertos A, et al. Tissue-specific regulation of potassium homeostasis by high doses of cationic amino acids. Springerplus. 2016;5:616.
https://www.doi.org/10.1186/s40064-016-2224-3
http://www.ncbi.nlm.nih.gov/pubmed/27330882?tool=bestpractice.com
Azole antifungals (e.g., ketoconazole)[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Beta-blockers (noncardioselective)[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Calcineurin inhibitors (e.g., cyclosporine, tacrolimus)[4]Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2020 Jan;97(1):42-61.
https://www.doi.org/10.1016/j.kint.2019.09.018
http://www.ncbi.nlm.nih.gov/pubmed/31706619?tool=bestpractice.com
[40]Hoorn EJ, Walsh SB, McCormick JA, et al. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med. 2011 Oct 2;17(10):1304-9.
http://www.ncbi.nlm.nih.gov/pubmed/21963515?tool=bestpractice.com
Digoxin[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Heparin[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[38]Baird DP, Hunter RW, Neary JJ. Hyperkalaemia on the surgical ward. BMJ. 2015 Oct 21;351:h5531.
http://www.ncbi.nlm.nih.gov/pubmed/26489645?tool=bestpractice.com
Isoflurane[4]Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2020 Jan;97(1):42-61.
https://www.doi.org/10.1016/j.kint.2019.09.018
http://www.ncbi.nlm.nih.gov/pubmed/31706619?tool=bestpractice.com
Lithium[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Mannitol[57]Fanous AA, Tick RC, Gu EY, et al. Life-threatening mannitol-induced hyperkalemia in neurosurgical patients. World Neurosurg. 2016 Jul;91:672.e5-9.
https://www.doi.org/10.1016/j.wneu.2016.04.021
http://www.ncbi.nlm.nih.gov/pubmed/27086258?tool=bestpractice.com
Nonsteroidal anti-inflammatory drugs[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Penicillins[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Pentamidine[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Potassium-sparing diuretics (e.g., amiloride, triamterene)[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Somatostatin[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Succinylcholine.[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
In particular, certain drugs (e.g., mannitol, arginine, succinylcholine, digoxin) cause hyperkalemia due to cellular redistribution. This list is not exhaustive and you should consult your local drug formulary for more information.
Physical exam
In general, there are no specific features on physical exam alone that lead to the diagnosis of hyperkalemia. However, always be alert to the diagnosis if there is severe bradycardia, which results from heart block. Other features may include:
Extrasystoles and cardiac pauses
Tachypnea, which is due to respiratory muscle weakness
Skeletal muscle weakness or flaccid muscle paralysis with depressed or absent deep tendon reflexes
Hypoactive or absent bowel sounds if ileus is present.
Initial investigations
Serum potassium
Order serum potassium in all patients.[12]Rossignol P, Legrand M, Kosiborod M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Nov;113(pt a):585-91.
https://www.doi.org/10.1016/j.phrs.2016.09.039
http://www.ncbi.nlm.nih.gov/pubmed/27693804?tool=bestpractice.com
In an emergency setting, measure potassium using arterial or venous blood gas while waiting for the results from formal laboratory measurement.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
There is no universally accepted definition of hyperkalemia. However, many guidelines use a threshold of serum potassium ≥5.5 mEq/L (≥5.5 mmol/L) and the European Resuscitation Council classification of severity of hyperkalemia, which is as follows:[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[3]Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council Guidelines 2021: cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.
https://www.doi.org/10.1016/j.resuscitation.2021.02.011
http://www.ncbi.nlm.nih.gov/pubmed/33773826?tool=bestpractice.com
5.5 to 5.9 mEq/L (5.5 to 5.9 mmol/L): mild
6.0 to 6.4 mEq/L (6.0 to 6.4 mmol/L): moderate
≥6.5 mEq/L (≥6.5 mmol/L): severe.
Note that Kidney Disease: Improving Global Outcomes (KDIGO) uses a similar scale but also adds ECG changes to categorize severity; according to the KDIGO scale, mild hyperkalemia with ECG changes increases the severity level to moderate, and moderate hyperkalemia with ECG changes increases the severity level to severe.[4]Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2020 Jan;97(1):42-61.
https://www.doi.org/10.1016/j.kint.2019.09.018
http://www.ncbi.nlm.nih.gov/pubmed/31706619?tool=bestpractice.com
It is useful to know whether serum or plasma was used for potassium measurement. Plasma potassium concentrations are on average usually 0.1 to 0.4 mEq/L (0.1 to 0.4 mmol/L) lower than serum levels due to release of potassium from platelets during coagulation.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
If serum potassium is elevated, exclude pseudohyperkalemia (due to potassium released from blood cells during in vitro coagulation or errors in sample collection and/or storage) and cellular redistribution of potassium.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
Assess the probability of these by reviewing the medical history (e.g., for diabetes, heart failure, chronic kidney disease), drug history, and other blood results (e.g., complete blood count), as well as repeating the serum potassium level.[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
See Differentials.
12-lead ECG
Obtain an urgent 12-lead ECG in all hospitalized patients with a serum potassium level of ≥6.0 mEq/L (≥6 mmol/L; or use the threshold in your local protocol) to assess for changes associated with hyperkalemia, which can help to determine the urgency and type of treatment required.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
Note that the ECG is often normal in hyperkalemia.[4]Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2020 Jan;97(1):42-61.
https://www.doi.org/10.1016/j.kint.2019.09.018
http://www.ncbi.nlm.nih.gov/pubmed/31706619?tool=bestpractice.com
[12]Rossignol P, Legrand M, Kosiborod M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Nov;113(pt a):585-91.
https://www.doi.org/10.1016/j.phrs.2016.09.039
http://www.ncbi.nlm.nih.gov/pubmed/27693804?tool=bestpractice.com
ECG changes may progress from peaked T waves to prolonged PR interval and progressive widening of QRS complex, followed by sine wave patterns, ventricular fibrillation, and asystole.[4]Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2020 Jan;97(1):42-61.
https://www.doi.org/10.1016/j.kint.2019.09.018
http://www.ncbi.nlm.nih.gov/pubmed/31706619?tool=bestpractice.com
If hyperkalemia-related changes are present, they may correlate with the severity and rate of rise of serum potassium.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
However, be aware that ECG changes are dependent on a variety of other factors (e.g., concurrent electrolyte abnormalities, acid-base status, prior cardiac injury), and relying on or expecting progressive ECG changes with increasing severity of hyperkalemia may be misleading and potentially dangerous.[2]Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.
https://www.doi.org/10.1002/emp2.12572
http://www.ncbi.nlm.nih.gov/pubmed/34632453?tool=bestpractice.com
[Figure caption and citation for the preceding image starts]: ECG changes in people with hyperkalemiaBMJ 2009; 339:b4114. Copyright ©2009 by the BMJ Publishing Group [Citation ends].
Other blood tests
Renal chemistry (includes, in addition to potassium as discussed above, sodium, chloride, bicarbonate, BUN, and creatinine): order to check for kidney dysfunction as a cause of hyperkalemia, and to exclude cellular redistribution of potassium.
Plasma glucose: order to exclude hyperglycemia, which causes cellular redistribution of potassium. This is useful in patients with known or suspected diabetes and when diabetic ketoacidosis is likely.
Serum calcium: order to check for hypocalcemia as this will potentiate the toxicity of hyperkalemia. Calcium will also be low in rhabdomyolysis, which is a cause of hyperkalemia.
CBC: order (or review a recent CBC) if pseudohyperkalemia is suspected to exclude a hematologic disorder.[1]Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].
https://ukkidney.org/sites/renal.org/files/RENAL%20ASSOCIATION%20HYPERKALAEMIA%20GUIDELINE%20-%20JULY%202022%20V2_0.pdf
Hyperkalemia in the setting of significantly elevated white cell count or platelet count with no obvious risk factor for hyperkalemia indicates pseudohyperkalemia.
Other investigations
Consider other investigations depending on the suspected underlying cause. These include:
Uric acid and phosphorus if tumor lysis syndrome is suspected.
Creatine kinase if rhabdomyolysis is suspected.[64]Poels PJ, Gabreëls FJ. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg. 1993 Sep;95(3):175-92.
https://www.doi.org/10.1016/0303-8467(93)90122-w
http://www.ncbi.nlm.nih.gov/pubmed/8242960?tool=bestpractice.com
[65]Knochel JP. Rhabdomyolysis and myoglobinuria. Annu Rev Med. 1982;33:435-43.
https://www.doi.org/10.1146/annurev.me.33.020182.002251
http://www.ncbi.nlm.nih.gov/pubmed/6282181?tool=bestpractice.com
Serum digoxin level if the patient is taking digoxin or if suicide is known to have been attempted with digoxin ingestion.
Cortisol and aldosterone levels if mineralocorticoid deficiency is suspected (e.g., primary adrenal insufficiency [Addison disease]) and other potential causes of hyperkalemia have been excluded. See Primary adrenal insufficiency.
Urine pH if renal tubular acidosis is suspected.[66]Morris RC Jr. Renal tubular acidosis. Mechanisms, classification and implications. N Engl J Med. 1969 Dec 18;281(25):1405-13.
http://www.ncbi.nlm.nih.gov/pubmed/4901460?tool=bestpractice.com
[67]Rodríguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002 Aug;13(8):2160-70.
https://www.doi.org/10.1097/01.asn.0000023430.92674.e5
http://www.ncbi.nlm.nih.gov/pubmed/12138150?tool=bestpractice.com
[68]Batlle D, Moorthi KM, Schlueter W, et al. Distal renal tubular acidosis and the potassium enigma. Semin Nephrol. 2006 Nov;26(6):471-8.
http://www.ncbi.nlm.nih.gov/pubmed/17275585?tool=bestpractice.com
See Renal tubular acidosis.
Plasma renin activity if pseudohypoaldosteronism is suspected.
24-hour urine potassium excretion to distinguish renal from extrarenal causes of hyperkalemia.
Plasma and urine potassium and osmolality to calculate transtubular potassium gradient, if values from 24-hour urine potassium secretion are difficult to interpret or to identify impaired distal tubular secretion of potassium due to hypoaldosteronism or aldosterone resistance.